Skip to main content

Table 3 Diagnostic and treatment cohort characteristics

From: Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives

 

Total (n = 69) N (%)

Localized (n = 38) N (%)

Systemic (n = 31) N (%)

Healthcare provider(s) seen before diagnosis

 Primary care provider only

23 (33.3%)

8 (21.1%)

15 (48.4%)

 Dentist only

4 (5.8%)

1 (2.6%)

3 (9.7%)

 Dermatology only

12 (17.4%)

12 (31.6%)

0

 Multiple providers including primary care, dermatology, dentist, and other specialists

30 (43.5%)

17 (44.7%)

13 (41.9%)

Healthcare provider who made diagnosis

 Primary Care Provider

6 (8.7%)

2 (5.3%)

4 (12.9%)

 Dermatology

24 (34.8%)

24 (63.2%)

0

 Rheumatology

35 (50.7%)

12 (31.6%)

23 (74.2%)

 Other

4 (5.8%)

0

4 (12.9%)

How much time passed between bringing your child to medical attention and a diagnosis?

 Less than 1 month

14 (20.2%)

5 (13.2%)

9 (29.0%)

 Between 1 and 3 months

16 (23.2%)

9 (23.7%)

7 (22.6%)

 Between 3 and 6 months

10 (14.5%)

5 (13.2%)

5 (16.1%)

 Between 6 and 12 months

10 (14.5%)

6 (15.8%)

4 (12.9%)

 Between 1 and 2 years

9 (13.0%)

8 (21.1%)

1 (3.2%)

 Between 2 and 4 years

5 (7.2%)

2 (5.3%)

3 (9.7%)

 More than 4 years

5 (7.2%)

3 (7.9%)

2 (6.5%)

How much time passed between initial symptoms and initiation of systemic medication(s)?

 Less than 3 months

16 (23.2%)

9 (23.7%)

7 (22.6%)

 Between 3 and 6 months

15 (21.7%)

6 (15.8%)

9 (29.0%)

 Between 6 and 12 months

9 (13.0%)

4 (10.5%)

5 (16.1%)

 Between 1 and 2 years

10 (14.5%)

8 (21.1%)

2 (6.5%)

 Between 2 and 4 years

11 (15.9%)

6 (15.8%)

5 (16.1%)

 More than 4 years

4 (5.8%)

2 (5.3%)

2 (6.5%)

 Not applicable

4 (5.8%)

3 (7.9%)

1 (3.2%)